KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 180 filers reported holding KARUNA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,344,679 | -21.8% | 13,860 | +0.2% | 0.00% | 0.0% |
Q2 2023 | $2,997,980 | +28.7% | 13,833 | +7.9% | 0.00% | 0.0% |
Q1 2023 | $2,329,912 | +116.0% | 12,825 | +133.8% | 0.00% | +100.0% |
Q4 2022 | $1,078,587 | -1.4% | 5,486 | +12.7% | 0.00% | 0.0% |
Q3 2022 | $1,094,000 | +121.9% | 4,868 | +24.9% | 0.00% | – |
Q2 2022 | $493,000 | +0.6% | 3,898 | +0.8% | 0.00% | – |
Q1 2022 | $490,000 | -3.2% | 3,866 | +0.2% | 0.00% | – |
Q4 2021 | $506,000 | +115.3% | 3,860 | +101.5% | 0.00% | – |
Q3 2021 | $235,000 | – | 1,916 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |